The European Malignant Hyperthermia Group (EMHG) currently recognises an ever-growing list of 66 pathogenic/likely pathogenic variants in RYR1 and two in CACNA1S (encodes α-subunit of the dihydropyridine receptor) for MH diagnosis [1]. Here, RYR1 is linked to Malignant hyperthermia.